Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods

Nephron

Volumn 75, Issue 4, 1997, Pages 438-443

  Tsuchida, K ^a   Takemoto, Y ^a   Yamagami, S ^a   Edney, H ^a   Niwa, M ^b   Tsuchiya, M ^c   Kishimoto, T ^a   Shaldon, S ^d  

^a OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^b Osaka Prefecture University   (Japan)

^c FUJIFILM Wako Pure Chemical Corporation   (Japan)

^d NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Contamination of dialysate; Endotoxin; Limulus amebocyte lysate; Peptidoglycan; Silkworm larvae plasma; Synergic effect

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MURAMYL DIPEPTIDE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL LYSATE; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; DIALYSATE; FEMALE; HUMAN; HUMAN CELL; LIMULUS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE OSMOSIS; SILKWORM;

EID: 0030914223     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189582     Document Type: Article

References (13)

1. Steven M, Gordon CW. Oettinger LA, Bland A, Jamie C. Oliver MJ. Arduino J. Sonia M. Aguero M. Sigrid KM, Martin SF. William RJ: Pyrogenic reactions in patients receiving conventional. high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysalc containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992:2:1436-1444.
2. Bambauer R, Walther J. Meyer S. Osl S, Schauer M. Jung WK. Gohl H. Vienken H: Bacteria-and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 1994:18:188-192.
3. Yoshida H, Ochiai M. Ashida M: Beta-1,3-glu-can receptor and pcptidoglycan receptor are present as separate entities within insect pro-phcnoloxidasc activating system. Biochem Bio-phvs Res Commun 1986:141:1177-1184.
4. Bristol LA. Durum SK. F.isenberg SP: Differential regulation of group A streptococcal pep-tidoglvcan-polysaccharide PG-APSFstimuIat-cd macrophage production of IL-I by rat strains susceptible and resistant to PG-APS-induced arthritis. Cell Immunol 1993:149: 130-143.
5. Timmerman CP. Mattsson E, Matincz L, Graaf LD. Van Ja., Verbrugh HA., Verhoef J., Fleer A: Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal pcptidoglycans. Infcc Immun 1993;10:4167-4172.
6. Farielle E. Arlette A. Rita C, Ledcrer E: Minimal structural requirements for adjuvant activity of bacterial pcptidoglycan derivatives. Biochem Biophys Res Commun 1974:59:1317-1325.
7. Dinarello CA. Krueger JM: Induction of interleukin I by synthetic and naturally occurring muramylpcptides. Fed Proc 1986:45:2545-2548.
8. Takada H. Galanos C: Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptidc mice. Infect Immun 1978:55:409-413.
9. van Yperselc de Strihou C, Jadoul M. Malghem J. Maldague B. Jamart J: Effect of dialysis membrane and patient’s age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991:39: 1012-1019.
10. Mary W. Vermeulen G. Gray R: Processing of bacillus subtilis pcptidoglycan by a mouse macrophage cell line. Infect Immun 1984:46:476-483.
11. Nagao S, Akigawa K. Yamada S, Yagawa K, Tokunaga T. Kotani S: Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). Microbiol Immunol 1990;34:323-335.
12. Ronald L. Marcia MB. Nelson NH: Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocyte. J Infect Dis 1993:168:135-142.
13. Willem HA, Dokter A. Dijkstra J. Koopmans SB. Ben KS. Wolfgang K. Halie MR. Vclicnga E: G(Anh)MTetra. A natural bacterial cell wall breakdown product, induces interleukin-1B and intcrleukin-6 expression. J Biol Chem 1994:269:4201-4206.